Shwachman–Diamond syndrome (SDS) is a rare inherited disorder characterized by bone marrow (BM) dysfunction and exocrine pancreatic insufficiency. SDS patients have an increased risk for myelodisplastic syndrome and acute myeloid leukemia. Mesenchymal stem cells (MSCs) are the key component of the hematopoietic microenvironment and are relevant in inducing genetic mutations leading to leukemia. However, their role in SDS is still unexplored. We demonstrated that morphology, growth kinetics and expression of surface markers of MSCs from SDS patients (SDS-MSCs) were similar to normal MSCs. Moreover, SDS-MSCs were able to differentiate into mesengenic lineages and to inhibit the proliferation of mitogen-activated lymphocytes. We demonstrated in an in vitro coculture system that SDS-MSCs, significantly inhibited neutrophil apoptosis probably through interleukin-6 production. In a long-term coculture with CD34þ-sorted cells, SDS-MSCs were able to sustain CD34þ cells survival and to preserve their stemness. Finally, SDS-MSCs had normal karyotype and did not show any chromosomal abnormality observed in the hematological components of the BM of SDS patients. Despite their pivotal role in the hematopoietic stem cell niche, our data suggest that MSC themselves do not seem to be responsible for the hematological defects typical of SDS patients.
Mesenchymal stem cells from Shwachman–Diamond syndrome patients display normal functions and do not contribute to hematological defects / V. Andre, D. Longoni, S. Bresolin, C. Cappuzzello, E. Dander, M. Galbiati, C. Bugarin, A. Di Meglio, E. Nicolis, E. Maserati, M. Serafini, A. Warren, G. te Kronnie, G. Cazzaniga, L. Sainati, M. Cipolli, A. Biondi, G D’Amico. - In: BLOOD CANCER JOURNAL. - ISSN 2044-5385. - 2:10(2012 Oct 12), pp. e94.1-e94.7.
|Titolo:||Mesenchymal stem cells from Shwachman–Diamond syndrome patients display normal functions and do not contribute to hematological defects|
ANDRE', VALENTINA ISABELLA (Primo)
|Parole Chiave:||Shwachman–Diamond syndrome; mesenchymal stem cells; bone marrow failure; SBDS|
|Settore Scientifico Disciplinare:||Settore MED/05 - Patologia Clinica|
Settore MED/04 - Patologia Generale
Settore BIO/13 - Biologia Applicata
|Data di pubblicazione:||12-ott-2012|
|Data ahead of print / Data di stampa:||18-set-2012|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1038/bcj.2012.40|
|Appare nelle tipologie:||01 - Articolo su periodico|